Addressing Industry Challenges In mRNA Product Commercialization

The rapid development and approval of mRNA-based vaccines during the COVID-19 pandemic has spurred a renewed interest in mRNA technology, with scientists exploring new application areas such as oncology, HIV, rare diseases, and even personalized medicine. While the speed of production and flexibility of mRNA are appealing, several industry challenges must still be addressed to realize the full potential and further expand its use.

View this educational webinar regarding key challenge areas for mRNA-based product developers and the innovative strategies being used to address them.

Learning Objectives Include:

• Process optimization opportunities for in vitro transcription, purification, and encapsulation
• Novel mRNA delivery systems and other innovations
• Strategies to improve storage and supply chain logistics
• Navigating an uncertain regulatory environment
• Overview of Thermo Fisher Scientific’s experience, capacity, and integrated mRNA development and manufacturing services